Introduction
The field of medicinal chemistry is in a perpetual state of evolution, as dedicated researchers continuously explore novel compounds and their potential applications. Among the various groups of compounds that have garnered considerable attention in recent years, rakicidins stand out prominently. This attention has been particularly pronounced in the context of addressing the issue of Imatinib resistance in chronic myeloid leukemia (CML). In this extensive analysis, we will delve deep into the fascinating realm of rakicidins, with a special focus on unraveling the intricacies of Rakicidin Structure-Activity Relationships and drawing. . .
All of the university assignments are only visible to premium users. Get Premium Access only at £19.